{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:32:02Z","timestamp":1770420722892,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"am","delay-in-days":274,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jsbmb.2022.106103","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:30:58Z","timestamp":1648711858000},"page":"106103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Bird\u2019s eye view analysis of in situ cholesterol metabolic pathways in breast cancer patients and its clinicopathological significance in their subtypes"],"prefix":"10.1016","volume":"221","author":[{"given":"Shinkichi","family":"Kosaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keely","family":"McNamala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narumi","family":"Harada-Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jsbmb.2022.106103_bib1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.jsbmb.2022.106103_bib2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s12282-020-01139-3","article-title":"Annual report of the Japanese Breast Cancer Registry for 2017","volume":"27","author":"Hayashi","year":"2020","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.jsbmb.2022.106103_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-021-06288-3","article-title":"Breast cancer, diabetes mellitus and glucagon-like peptide-1 receptor toward exploring their possible associations","volume":"189","author":"Hashimoto Takigami","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.jsbmb.2022.106103_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41598-020-80668-5","article-title":"L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism","volume":"11","author":"Sato","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.jsbmb.2022.106103_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11306-019-1610-6","article-title":"A metabolic profile of routine needle biopsies identified tumor type specific metabolic signatures for breast cancer stratification: a pilot study","volume":"15","author":"Harada-Shoji","year":"2019","journal-title":"Metabolomics"},{"issue":"18","key":"10.1016\/j.jsbmb.2022.106103_bib6","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-14-1756","article-title":"Obesity, cholesterol metabolism, and breast cancer pathogenesis","volume":"74","author":"McDonnell","year":"2014","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.jsbmb.2022.106103_bib7","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-15-2613","article-title":"The role of cholesterol in cancer","volume":"76","author":"Kuzu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106103_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.nu.12.070192.002135","article-title":"Serum cholesterol and cancer risk: an epidemiologic perspective","volume":"12","author":"Kritchevsky","year":"1992","journal-title":"Annu. Rev. Nutr."},{"issue":"12","key":"10.1016\/j.jsbmb.2022.106103_bib9","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1200\/JCO.2010.31.5200","article-title":"Total cholesterol and cancer risk in a large prospective study in Korea","volume":"29","author":"Kitahara","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jsbmb.2022.106103_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/annonc\/mdr155","article-title":"Dietary cholesterol intake and cancer","volume":"23","author":"Hu","year":"2012","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.jsbmb.2022.106103_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188394","article-title":"Cholesterol metabolism: new functions and therapeutic approaches in cancer","volume":"1874","author":"Xu","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jsbmb.2022.106103_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/978-3-319-48382-5_25","article-title":"Obesity-associated breast cancer: analysis of risk factors","volume":"960","author":"Engin","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2022.106103_bib13","first-page":"1","article-title":"Cholesterol metabolism and colon cancer","volume":"17","author":"Broitman","year":"1993","journal-title":"Prog Food Nutr. Sci."},{"key":"10.1016\/j.jsbmb.2022.106103_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.682911","article-title":"Cholesterol metabolic reprogramming in cancer and its pharmacological modulation as therapeutic strategy","volume":"11","author":"Giacomini","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.jsbmb.2022.106103_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jsbmb.2022.106103_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/ijms21144822","article-title":"Obesity and cancer: 27-hydroxycholesterol, the missing link","volume":"21","author":"Asghari","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2022.106103_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.chemphyslip.2017.05.012","article-title":"27-hydroxycholesterol: a novel player in molecular carcinogenesis of breast and prostate cancer","volume":"207","author":"Marwarha","year":"2017","journal-title":"Chem. Phys. Lipids"},{"issue":"1","key":"10.1016\/j.jsbmb.2022.106103_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2010.11.005","article-title":"Role of cholesterol in the development and progression of breast cancer","volume":"178","author":"Llaverias","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.jsbmb.2022.106103_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13058-016-0713-5","article-title":"Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer","volume":"18","author":"Simigdala","year":"2016","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.jsbmb.2022.106103_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.coph.2012.07.006","article-title":"Cholesterol and prostate cancer","volume":"12","author":"Pelton","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jsbmb.2022.106103_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2407-12-25","article-title":"Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up","volume":"12","author":"Shafique","year":"2012","journal-title":"BMC Cancer"},{"issue":"19","key":"10.1016\/j.jsbmb.2022.106103_bib22","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jsbmb.2022.106103_bib23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1200\/JCO.2014.58.9564","article-title":"Statins do not protect against cancer: quite the opposite","volume":"33","author":"Ravnskov","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.jsbmb.2022.106103_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9343(01)00705-7","article-title":"Do statins cause cancer? A meta-analysis of large randomized clinical trials","volume":"110","author":"Bjerre","year":"2001","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.jsbmb.2022.106103_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.1996.03530250059028","article-title":"Carcinogenicity of lipid-lowering drugs","volume":"275","author":"Newman","year":"1996","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.jsbmb.2022.106103_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/qjmed\/hcr243","article-title":"The statin-low cholesterol-cancer conundrum","volume":"105","author":"Ravnskov","year":"2012","journal-title":"Qjm"},{"issue":"12","key":"10.1016\/j.jsbmb.2022.106103_bib27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1253\/circj.66.1087","article-title":"Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia","volume":"66","author":"Matsuzaki","year":"2002","journal-title":"Circ. J."},{"issue":"19","key":"10.1016\/j.jsbmb.2022.106103_bib28","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1001\/archinte.165.19.2264","article-title":"Serum lipids, lipid-lowering drugs, and the risk of breast cancer","volume":"165","author":"Eliassen","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jsbmb.2022.106103_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105566","article-title":"Plasma oxysterol levels in luminal subtype breast cancer patients are associated with clinical data","volume":"197","author":"Kloudova-Spalenkova","year":"2020","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106103_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jsbmb.2016.06.010","article-title":"Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study","volume":"169","author":"Dalenc","year":"2017","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"issue":"7","key":"10.1016\/j.jsbmb.2022.106103_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/ERC-16-0533","article-title":"Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer","volume":"24","author":"Kimbung","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"issue":"16","key":"10.1016\/j.jsbmb.2022.106103_bib32","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1111\/bph.15273","article-title":"Oxysterols in cancer management: from therapy to biomarkers","volume":"178","author":"Kloudova-Spalenkova","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.jsbmb.2022.106103_bib33","first-page":"290","article-title":"Breast cancer-major changes in the american joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jsbmb.2022.106103_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jsbmb.2017.12.012","article-title":"Improved detectability of sex steroids from frozen sections of breast cancer tissue using GC-triple quadrupole-MS","volume":"178","author":"Moon","year":"2018","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106103_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsbmb.2015.09.024","article-title":"Hair sterol signatures coupled to multivariate data analysis reveal an increased 7\u03b2-hydroxycholesterol production in cognitive impairment","volume":"155","author":"Son","year":"2016","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"issue":"8","key":"10.1016\/j.jsbmb.2022.106103_bib36","first-page":"716","article-title":"Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies","volume":"109","author":"McCarty","year":"1985","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"5","key":"10.1016\/j.jsbmb.2022.106103_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdu053","article-title":"Which threshold for ER positivity? a retrospective study based on 9639 patients","volume":"25","author":"Yi","year":"2014","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.jsbmb.2022.106103_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American society of clinical oncology\/college of american pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.jsbmb.2022.106103_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group","volume":"103","author":"Dowsett","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.jsbmb.2022.106103_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/s12282-012-0387-5","article-title":"Analysis of clinically relevant values of Ki-67 labeling index in Japanese breast cancer patients","volume":"21","author":"Tamaki","year":"2014","journal-title":"Breast Cancer"},{"issue":"3","key":"10.1016\/j.jsbmb.2022.106103_bib41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccell.2018.02.004","article-title":"PKM1 confers metabolic advantages and promotes cell-autonomous tumor cell growth","volume":"33","author":"Morita","year":"2018","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.jsbmb.2022.106103_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2013.10.006","article-title":"27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth","volume":"5","author":"Wu","year":"2013","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.jsbmb.2022.106103_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1530\/ERC-18-0572","article-title":"Host CYP27A1 expression is essential for ovarian cancer progression","volume":"26","author":"He","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2022.106103_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.maturitas.2017.07.014","article-title":"27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator","volume":"104","author":"He","year":"2017","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.jsbmb.2022.106103_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13058-020-01347-x","article-title":"CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients","volume":"22","author":"Kimbung","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"6162","key":"10.1016\/j.jsbmb.2022.106103_bib46","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jsbmb.2022.106103_bib47","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/onc.2012.113","article-title":"Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model","volume":"32","author":"Alikhani","year":"2013","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.jsbmb.2022.106103_bib48","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.tem.2017.03.002","article-title":"The role of oxysterols in human cancer","volume":"28","author":"Kloudova","year":"2017","journal-title":"Trends Endocrinol. Metab"},{"issue":"1","key":"10.1016\/j.jsbmb.2022.106103_bib49","first-page":"35","article-title":"Association between CYP7A1 and the risk of proximal colon cancer in Japanese","volume":"1","author":"Ito","year":"2010","journal-title":"Int. J. Mol. Epidemiol. Genet."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076022000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076022000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:09:10Z","timestamp":1760746150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076022000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":49,"alternative-id":["S0960076022000541"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2022.106103","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bird\u2019s eye view analysis of in situ cholesterol metabolic pathways in breast cancer patients and its clinicopathological significance in their subtypes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2022.106103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106103"}}